Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Cancer Discovery|December 12, 2013
Teaching an old dog new tricks: drug repositioning in small cell lung cancerJing Wang, Lauren Averett ByersCancer Cell|July 16, 2015
Altering the Course of Small Cell Lung Cancer: Targeting Cancer Stem Cells via LSD1 InhibitionC Allison Stewart, Lauren Averett ByersCancer|October 23, 2014
Small cell lung cancer: where do we go from here?Lauren Averett Byers, Charles M RudinCancer Discovery|September 4, 2014
A HER 1-2 punch: dual EGFR targeting deals resistance a deadly blowDon L Gibbons, Lauren Averett ByersCancer Discovery|October 3, 2019
Temozolomide plus PARP Inhibition in Small-Cell Lung Cancer: Could Patient-Derived Xenografts Accelerate Discovery of Biomarker Candidates?Jose M Pacheco, Lauren Averett ByersCancer Discovery|January 11, 2019
Evading the STING: LKB1 Loss Leads to STING Silencing and Immune Escape in KRAS-Mutant Lung CancersCarminia Maria Della Corte, Lauren Averett ByersTranslational Lung Cancer Research|March 15, 2018
Targeting DNA damage repair in small cell lung cancer and the biomarker landscapeTriparna Sen, Carl M Gay, Lauren Averett ByersCancers|February 23, 2019
Integrated Approaches for the Use of Large Datasets to Identify Rational Therapies for the Treatment of Lung CancersRobert J Cardnell, Lauren Averett Byers, Jing WangBritish Journal of Cancer|January 11, 2017
Giving AXL the axe: targeting AXL in human malignancyCarl M Gay, Kavitha Balaji, Lauren Averett ByersCancer Cell|January 18, 2020
This Is Our Cells Under Pressure: Decreased DNA Damage Repair in Response to Targeted Therapies Facilitates the Emergence of Drug-Resistant ClonesCarl M Gay, Christine M Parseghian, Lauren Averett ByersPageof 6